Hatem Bellâaj
- Co-authors
- Mohamed JmaïelAhmed Hadj KacemHabib HamamF. CheikhrouhouMoez ElloumiInès HadrichMohamed KsantiniStéphane Ranque
- Topics
- Chronic Myeloid Leukemia Treatments (5 papers)Gallbladder and Bile Duct Disorders (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)
- Journals
- Applied SciencesCancer Chemotherapy and PharmacologyJournal of Cancer Research and Clinical Oncology
- Partner nations
- TunisiaFranceUnited Kingdom
In The Last Decade
Hatem Bellâaj
28 papers receiving 287 citations
Peers
Comparison fields: 5 of 99
- Infectious Diseases 84
- Artificial Intelligence 79
- Epidemiology 71
- Hematology 37
- Cell Biology 33
Countries citing papers authored by Hatem Bellâaj
This map shows the geographic impact of Hatem Bellâaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatem Bellâaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatem Bellâaj more than expected).
Fields of papers citing papers by Hatem Bellâaj
This network shows the impact of papers produced by Hatem Bellâaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatem Bellâaj. The network helps show where Hatem Bellâaj may publish in the future.
Co-authorship network of co-authors of Hatem Bellâaj
This figure shows the co-authorship network connecting the top 25 collaborators of Hatem Bellâaj. A scholar is included among the top collaborators of Hatem Bellâaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatem Bellâaj. Hatem Bellâaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 5 | |
| 3 | 21 | |
| 4 | 52 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | 5 | |
| 8 | 16 | |
| 9 | 25 | |
| 10 | 1 | |
| 11 | 4 | |
| 12 | 18 | |
| 13 | 48 | |
| 14 | 13 | |
| 15 | 19 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | 0 | |
| 19 | 1 | |
| 20 | 5 |
About Hatem Bellâaj
Hatem Bellâaj is a scholar working on Hematology, Health Information Management and Genetics, having authored 32 papers that have together received 295 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Gallbladder and Bile Duct Disorders (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Health Informatics (11 citations), Health Information Management (21 citations) and Infectious Diseases (84 citations). Hatem Bellâaj has collaborated with scholars based in Tunisia, France and United Kingdom. Frequent co-authors include Mohamed Jmaïel, Ahmed Hadj Kacem, Habib Hamam, F. Cheikhrouhou, Moez Elloumi, Inès Hadrich, Mohamed Ksantini, Stéphane Ranque, Sourour Neji and Ali Ayadi. Their work appears in journals such as Applied Sciences, Cancer Chemotherapy and Pharmacology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.